Mace Rothenberg starts the year by stepping out of his top job in Pfizer R&D — as Stanford’s Aida Habtezion steps in
There’s a changing of the guard underway in the senior ranks of Pfizer’s R&D team.
Chief medical officer Mace Rothenberg, who helped lead the pharma giant to 6 new drug approvals in the last 2 years, is stepping aside from his high profile perch and handing the job to Aida Habtezion, a physician scientist who’s been doing research on leukocytes at Stanford.
Rothenberg put out the word on social media Monday, though he didn’t say just what he had on his mind for the next chapter in his career. He told me via LinkedIn, though, that he’s most interested in finding some key board positions where he can be most useful.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
